EuroBiotech: More Articles of Note


> Cassiopea posted more positive data on its pipeline. On Monday, the company reported interim data on clascoterone in androgenetic alopecia. Days later, Cassiopea added phase 2 genital wart data to its list of recent readouts. Release I More

> Takeda struck a deal to assess the feasibility of leon-nanodrugs’ MicroJet Reactor. Statement 

> Silence Therapeutics named David Horn Solomon as its CEO. Solomon ran Zealand Pharma from 2008 to 2015. Release


Veeva 2019 Unified Clinical Operations Survey

Share your thoughts in this quick survey. The first 50 qualified respondents will receive a $5 Amazon gift card, and, in appreciation for your time, all qualified survey respondents will be entered in a drawing to win a $50 Amazon gift card.

> Poxel posted data from a phase 1b NASH trial. The French biotech will now move the candidate into phase 2a. Statement

> Adaptimmune received clearance for dose escalation in its MAGE-A10 pilot studies. Release